SCHEMBL18587741

SCHEMBL18587741

Cc1ccc(S(=O)(=O)C(CN)C(=O)O)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 7/20 0.51
MMP9 P14780 6/20 0.51
MMP3 P08254 3/20 0.48
MMP13 P45452 3/20 0.48
ALDH1A1 P00352 2/20 0.46
SLC1A3 P43003 1/20 0.45
SLC1A2 P43004 1/20 0.45
SLC1A1 P43005 1/20 0.45
CA12 O43570 2/20 0.42
CA1 P00915 2/20 0.42
CA2 P00918 2/20 0.42
CA9 Q16790 2/20 0.42
CA3 P07451 1/20 0.42
CA6 P23280 1/20 0.42
CA5A P35218 1/20 0.42
CA7 P43166 1/20 0.42
CA5B Q9Y2D0 1/20 0.42
RECQL P46063 1/20 0.41
MMP1 P03956 1/20 0.41
MMP7 P09237 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28043061 0.84 MMP2 (0.52) MMP2MMP9MMP3MMP13ALDH1A1
SCHEMBL9570487 0.84 MMP2 (0.52) MMP2MMP9MMP3MMP13ALDH1A1
SCHEMBL28043062 0.84 MMP2 (0.52) MMP2MMP9MMP3MMP13ALDH1A1
SCHEMBL28040270 0.84 MMP2 (0.43) MMP2MMP9MMP3MMP13ALDH1A1
SCHEMBL27898507 0.84 MMP2 (0.43) MMP2MMP9MMP3MMP13ALDH1A1
SCHEMBL28823565 0.84 MMP2 (0.43) MMP2MMP9MMP3MMP13ALDH1A1
SCHEMBL8936409 0.83 MMP2 (0.51) MMP2MMP9MMP3MMP13ALDH1A1
SCHEMBL29033737 0.79 MMP9 (0.57) MMP2MMP9MMP3MMP13ALDH1A1
SCHEMBL8381021 0.77 SLC1A3 (0.53) MMP2MMP9MMP3MMP13ALDH1A1
SCHEMBL10420675 0.76 MMP9 (0.55) MMP2MMP9MMP3MMP13ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3344257-A1 NR2B SELECTIVE NMDA-RECEPTOR ANTAGONISTS FOR TREATMENT OF IMMUNE-MEDIATED INFLAMMATORY DISEASES Westfälische Wilhelms-Universität Münster (DE) 2018-07-11 EP disclosed
WO-2017036880-A1 NR2B SELECTIVE NMDA-RECEPTOR ANTAGONISTS FOR TREATMENT OF IMMUNE-MEDIATED INFLAMMATORY DISEASES Westfälische Wilhelms-Universität Münster (DE) 2017-03-09 WO disclosed